These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21492969)

  • 1. [Alzheimer's disease and vascular risk factors].
    Hanon O; Duron E
    Rev Med Interne; 2011 Jun; 32 Suppl 1():S17-21. PubMed ID: 21492969
    [No Abstract]   [Full Text] [Related]  

  • 2. Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?
    Richard F; Pasquier F
    J Alzheimers Dis; 2012; 32(3):765-72. PubMed ID: 22886010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.
    Casserly I; Topol E
    Lancet; 2004 Apr; 363(9415):1139-46. PubMed ID: 15064035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, hypertension-clustering factors and Alzheimer's disease.
    Skoog I; Gustafson D
    Neurol Res; 2003 Sep; 25(6):675-80. PubMed ID: 14503023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the major vascular risk factors related to Alzheimer's disease.
    Polidori MC; Pientka L; Mecocci P
    J Alzheimers Dis; 2012; 32(3):521-30. PubMed ID: 22836188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive frailty: Predementia syndrome and vascular risk factors.
    Panza F; D'Introno A; Colacicco AM; Capurso C; Parigi AD; Capurso SA; Caselli RJ; Pilotto A; Scafato E; Capurso A; Solfrizzi V
    Neurobiol Aging; 2006 Jul; 27(7):933-40. PubMed ID: 16023766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral atherosclerosis and oxidative stress in Alzheimer's disease.
    Rafael H
    J Alzheimers Dis; 2003 Dec; 5(6):479-80; author reply 481-2. PubMed ID: 14757939
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrophysiological comparison between patients with Binswanger's encephalopathy and Alzheimer's disease].
    Tachibana H; Kawabata K; Takeda M; Sugita M; Kondo J; Miyauchi M; Matsuoka A
    Rinsho Byori; 1991 Sep; 39(9):999-1004. PubMed ID: 1942575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease.
    de la Torre JC
    J Alzheimers Dis; 2012; 32(3):553-67. PubMed ID: 22842871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort.
    Sanz CM; Hanaire H; Vellas BJ; Sinclair AJ; Andrieu S;
    Diabet Med; 2012 Apr; 29(4):541-8. PubMed ID: 21913970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased homocysteine and decreased adenosine formation in Alzheimer's disease.
    Selley ML
    Neurol Res; 2004 Jul; 26(5):554-7. PubMed ID: 15265273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.
    Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ
    Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular risk factors and Alzheimer's disease].
    Regalado Doña PJ; Azpiazu Artigas P; Sánchez Guerra ML; Almenar Monfort C
    Rev Esp Geriatr Gerontol; 2009; 44(2):98-105. PubMed ID: 19268394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.
    Deschaintre Y; Richard F; Leys D; Pasquier F
    Neurology; 2009 Sep; 73(9):674-80. PubMed ID: 19720973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular risk factors and progression in Alzheimer's disease.
    Sakurai H; Hanyu H; Sato T; Kanetaka H; Shimizu S; Hirao K; Kikukawa M; Iwamoto T
    Geriatr Gerontol Int; 2011 Apr; 11(2):211-4. PubMed ID: 21143566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease could be "type 3 diabetes".
    Pilcher H
    Lancet Neurol; 2006 May; 5(5):388-9. PubMed ID: 16639835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Epidemiology of Alzheimer's disease].
    Dufouil C; Alpérovitch A
    Rev Prat; 2005 Nov; 55(17):1869-78. PubMed ID: 16396227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease.
    Xu W; Qiu C; Winblad B; Fratiglioni L
    Diabetes; 2007 Jan; 56(1):211-6. PubMed ID: 17192484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease.
    Kalback W; Esh C; Castaño EM; Rahman A; Kokjohn T; Luehrs DC; Sue L; Cisneros R; Gerber F; Richardson C; Bohrmann B; Walker DG; Beach TG; Roher AE
    Neurol Res; 2004 Jul; 26(5):525-39. PubMed ID: 15265270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on hypertension and Alzheimer's disease.
    Skoog I; Gustafson D
    Neurol Res; 2006 Sep; 28(6):605-11. PubMed ID: 16945211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.